Browsing Tag
Nanoscope Therapeutics Inc.
1 post
Can Nanoscope make severe retinitis pigmentosa treatable without knowing the mutation?
The FDA has accepted Nanoscope Therapeutics’ BLA for MOGENRY, a one-time optogenetic therapy designed to restore useful vision in severe retinitis pigmentosa regardless of the patient’s underlying mutation.